Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an <i>IDH1</i>-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.

Rittberg, Rebekah; Harlos, Craig; Rothenmund, Heidi; Das, Anirban; Tabori, Uri; Sinha, Namita; Singh, Harminder; Chodirker, Bernie; Kim, Christina A

Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.

Rittberg, Rebekah; Harlos, Craig; Rothenmund, Heidi; Das, Anirban; Tabori, Uri; Sinha, Namita; Singh, Harminder; Chodirker, Bernie; Kim, Christina A.

Afiliación

Rittberg R; Section of Hematology/Oncology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Harlos C; Section of Hematology/Oncology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Rothenmund H; Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Das A; Division of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON M5G 1X8, Canada.
Tabori U; Division of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, ON M5G 1X8, Canada.
Sinha N; Department of Pathology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.
Singh H; Section of Gastroenterology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
Chodirker B; Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Kim CA; Section of Hematology/Oncology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.

Curr Oncol ; 28(1): 757-766, 2021 02 01.

Article en En | MEDLINE | ID: mdl-33535600

Asunto(s)

Astrocitoma; Neoplasias Encefálicas; Síndromes Neoplásicos Hereditarios; Adolescente; Astrocitoma/tratamiento farmacológico; Astrocitoma/genética; Neoplasias Encefálicas/tratamiento farmacológico; Neoplasias Encefálicas/genética; Neoplasias Colorrectales; Femenino; Humanos; Inhibidores de Puntos de Control Inmunológico; Isocitrato Deshidrogenasa/genética

Palabras clave

CMMRD; adjuvant therapy; checkpoint inhibitors; constitutional mismatch repair deficiency; immunotherapy; screening; surveillance; tumor mutational burden

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Astrocitoma / Síndromes Neoplásicos Hereditarios / Neoplasias Encefálicas Límite: Adolescent / Female / Humans Idioma: En Revista: Curr Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google